CD8A and neoplasm: Analysis of murine tumor tissues harvested 12, 16, and 26 days after tumor cell injection (2, 6, and 16 days after the initiation of PTX treatment, respectively), showed an initial increase, followed by a gradual reduction in CD8+ T cell homing to the tumors (Fig. 2G).